|
Cell Cycle
Citations 41-50 of 231 total displayed.
|
Past content
(since May 2000):
|
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma
- Abel Sánchez-Aguilera, Carlos Montalbán, Paloma de la Cueva, Lydia Sánchez-Verde, Manuel M. Morente, Mónica García-Cosío, José García-Laraña, Carmen Bellas, Mariano Provencio, Vicens Romagosa, Alberto Fernández de Sevilla, Javier Menárguez, Pilar Sabín, María J. Mestre, Miguel Méndez, Manuel F. Fresno, Concepción Nicolás, Miguel A. Piris, and Juan F. García, for the Spanish Hodgkin Lymphoma Study Group
Blood 2006; 108: 662-668.
[Abstract]
[Full text]
[PDF]
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
- Deepa Bhojwani, Huining Kang, Naomi P. Moskowitz, Dong-Joon Min, Hokyung Lee, Jeffrey W. Potter, George Davidson, Cheryl L. Willman, Michael J. Borowitz, Ilana Belitskaya-Levy, Stephen P. Hunger, Elizabeth A. Raetz, and William L. Carroll
Blood 2006; 108: 711-717.
[Abstract]
[Full text]
[PDF]
A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation
- Cristina Rubiolo, Daniela Piazzolla, Katrin Meissl, Hartmut Beug, Johannes C. Huber, Andrea Kolbus, and Manuela Baccarini
Blood 2006; 108: 152-159.
[Abstract]
[Full text]
[PDF]
Role of transforming growth factor- in hematologic malignancies
- Mei Dong and Gerard C. Blobe
Blood 2006; 107: 4589-4596.
[Abstract]
[Full text]
[PDF]
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival
- Diana Starlets, Yael Gore, Inbal Binsky, Michal Haran, Nurit Harpaz, Lev Shvidel, Shirly Becker-Herman, Alain Berrebi, and Idit Shachar
Blood 2006; 107: 4807-4816.
[Abstract]
[Full text]
[PDF]
Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis
- Binghui Li, Nan Jia, Reuben Kapur, and Kristin T. Chun
Blood 2006; 107: 4291-4299.
[Abstract]
[Full text]
[PDF]
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide–induced apoptosis
- Paolo Lunghi, Antonio Costanzo, Luigi Salvatore, Nelida Noguera, Laura Mazzera, Antonio Tabilio, Francesco Lo-Coco, Massimo Levrero, and Antonio Bonati
Blood 2006; 107: 4549-4553.
[Abstract]
[Full text]
[PDF]
Growth inhibition and apoptosis in human Philadelphia chromosome-positive lymphoblastic leukemia cell lines by treatment with the dual PPAR / ligand TZD18
- Hongyu Liu, Chuanbing Zang, Martin H. Fenner, Dachuan Liu, Kurt Possinger, H. Phillip Koeffler, and Elena Elstner
Blood 2006; 107: 3683-3692.
[Abstract]
[Full text]
[PDF]
Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis
- Claudio Talora, Samantha Cialfi, Christian Oliviero, Rocco Palermo, Monica Pascucci, Luigi Frati, Alessandra Vacca, Alberto Gulino, and Isabella Screpanti
Blood 2006; 107: 3313-3320.
[Abstract]
[Full text]
[PDF]
Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation
- Hana Raslova, Véronique Baccini, Lamya Loussaief, Béatrice Comba, Jérôme Larghero, Najet Debili, and William Vainchenker
Blood 2006; 107: 2303-2310.
[Abstract]
[Full text]
[PDF]
|
|
